Clinical Trial Update: Comparison of Gadobutrol and Gadobenate Dimeglumin for Delayed Enhancement Cardiac MRI [Phase 2]

View source ↗

Summary

Phase 2 trial comparing gadobutrol with gadobenate dimeglumin for delayed enhancement cardiac MRI in subacute or chronic myocardial infarction; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subacute Chronic Myocardial Infarction

Drugs mentioned

• GADOBUTROL (gadobutrol)
• gadobenate dimeglumin (gadobenate dimeglumin)

Snippet

Sponsor: Technical University of Munich | Conditions: Subacute/Chronic Myocardial Infarction | Phase 2 | Status: COMPLETED